Literature DB >> 22923371

Dietary trans-fatty acid induced NASH is normalized following loss of trans-fatty acids from hepatic lipid pools.

Brent A Neuschwander-Tetri1, David A Ford, Sahaja Acharya, George Gilkey, Metin Basaranoglu, Laura H Tetri, Elizabeth M Brunt.   

Abstract

Previous experiments in mice showed that dietary trans-fats could play a role in non-alcoholic steatohepatitis (NASH) yet little is known about the accumulation trans-fats in hepatic lipid pools in relationship to liver injury. NASH is also associated with obesity yet improves with only modest weight loss. To distinguish the role of obesity versus sustained consumption of a trans-fat containing diet in causing NASH, mice with obesity and NASH induced by consuming a high trans-fat diet for 16 weeks were subsequently fed standard chow or maintained on trans-fat chow for another 8 weeks. The accumulation, partitioning and loss of trans-fats in the major hepatic lipid pools during and after trans-fat consumption were determined. Obese mice switched to standard chow remained obese but steatohepatitis improved. trans-fats were differentially incorporated into the major hepatic lipid pools and the loss of trans-fats after crossover to control chow was greatest in the cholesteryl ester pool. In summary, dietary changes can improve the biochemical and histopathological changes of NASH despite persistent obesity in mice. Analysis of hepatic lipids confirmed that dietary trans-fats accumulate in the major lipid pools and are released differentially with diet normalization. The substantial loss of trans-fats from the cholesteryl ester pool in parallel with improvement in NASH suggests that this pool of trans-fats could play a role in the pathogenesis of NASH.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22923371      PMCID: PMC3473077          DOI: 10.1007/s11745-012-3709-7

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  48 in total

Review 1.  Management of nonalcoholic fatty liver disease: weight control.

Authors:  Iliana Bouneva; Donald F Kirby
Journal:  Clin Liver Dis       Date:  2004-08       Impact factor: 6.126

Review 2.  Nonalcoholic fatty liver disease in individuals with severe obesity.

Authors:  Paul Haynes; Suthat Liangpunsakul; Naga Chalasani
Journal:  Clin Liver Dis       Date:  2004-08       Impact factor: 6.126

3.  Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia.

Authors:  Alan D Attie; Ronald M Krauss; Mark P Gray-Keller; Alison Brownlie; Makoto Miyazaki; John J Kastelein; Aldons J Lusis; Anton F H Stalenhoef; Jonathan P Stoehr; Michael R Hayden; James M Ntambi
Journal:  J Lipid Res       Date:  2002-11       Impact factor: 5.922

4.  The deposition of polyunsaturated fatty acids in the rat fed partially hydrogenated vegetable oil.

Authors:  J L Beare-Rogers
Journal:  J Am Oil Chem Soc       Date:  1970-12       Impact factor: 1.849

5.  Beta-oxidation of the geometric and positional isomers of octadecenoic acid by rat heart and liver mitochondria.

Authors:  L D Lawson; R T Holman
Journal:  Biochim Biophys Acta       Date:  1981-07-24

6.  beta-Oxidation of the coenzyme A esters of vaccenic, elaidic, and petroselaidic acids by rat heart mitochondria.

Authors:  L D Lawson; F A Kummerow
Journal:  Lipids       Date:  1979-05       Impact factor: 1.880

7.  Incorporation of dietary cis and trans isomers of octadecenoate in lipid classes of liver and hepatoma.

Authors:  R Wood; F Chumbler; R Wiegand
Journal:  J Biol Chem       Date:  1977-03-25       Impact factor: 5.157

8.  Comparison of cis and trans fatty acid containing phosphatidylcholines on membrane properties.

Authors:  Charles Roach; Scott E Feller; Jesse A Ward; Saame Raza Shaikh; Mustapha Zerouga; William Stillwell
Journal:  Biochemistry       Date:  2004-05-25       Impact factor: 3.162

9.  beta-Oxidation of the coenzyme A esters of elaidic, oleic, and stearic acids and their full-cycle intermediates by rat heart mitochondria.

Authors:  L D Lawson; F A Kummerow
Journal:  Biochim Biophys Acta       Date:  1979-05-25

10.  Incorporation and disappearance of trans fatty acids in rat tissues.

Authors:  C E Moore; R B Alfin-Slater; L Aftergood
Journal:  Am J Clin Nutr       Date:  1980-11       Impact factor: 7.045

View more
  19 in total

Review 1.  Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction.

Authors:  Metin Basaranoglu; Gokcen Basaranoglu; Elisabetta Bugianesi
Journal:  Hepatobiliary Surg Nutr       Date:  2015-04       Impact factor: 7.293

2.  Differential regulation of ABCA1 and macrophage cholesterol efflux by elaidic and oleic acids.

Authors:  Fei Shao; David A Ford
Journal:  Lipids       Date:  2013-06-26       Impact factor: 1.880

3.  Significant cohort of non-alcoholic fatty liver disease with portal vein thrombosis in transplant waiting list.

Authors:  Metin Basaranoglu; Sonia M Najjar; Ali Ebag Demirbag; Hakan Senturk
Journal:  World J Hepatol       Date:  2016-03-08

4.  Nonalcoholic fatty liver may increase the risk of operation in patients with fatty liver and the frequency of cancer in their first-degree relatives.

Authors:  Metin Basaranoglu; Billur Canbakan; Kemal Yildiz; Bahadir Ceylan; Birol Baysal; Omer Uysal; Hakan Senturk
Journal:  Wien Klin Wochenschr       Date:  2015-04-14       Impact factor: 1.704

Review 5.  Recent advances in the development of farnesoid X receptor agonists.

Authors:  Ahmad H Ali; Elizabeth J Carey; Keith D Lindor
Journal:  Ann Transl Med       Date:  2015-01

6.  The role of REV-ERB in NASH.

Authors:  Kristine Griffett; Matthew E Hayes; Michael P Boeckman; Thomas P Burris
Journal:  Acta Pharmacol Sin       Date:  2022-02-25       Impact factor: 7.169

Review 7.  Fructose as a key player in the development of fatty liver disease.

Authors:  Metin Basaranoglu; Gokcen Basaranoglu; Tevfik Sabuncu; Hakan Sentürk
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

8.  Managing the Burden of Non-NASH NAFLD.

Authors:  Christopher J Danford; Jorge E Sanchez; Kathleen E Corey
Journal:  Curr Hepatol Rep       Date:  2017-10-27

Review 9.  The Global Nonalcoholic Fatty Liver Disease Epidemic: What a Radiologist Needs to Know.

Authors:  Keith Pereira; Jason Salsamendi; Javier Casillas
Journal:  J Clin Imaging Sci       Date:  2015-05-29

Review 10.  Nonalcoholic Fatty Liver Disease.

Authors:  Lingling Ding; Yvonne Oligschlaeger; Ronit Shiri-Sverdlov; Tom Houben
Journal:  Handb Exp Pharmacol       Date:  2022
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.